Resumo Fundamento Embora tenha havido melhorias significativas no tratamento da insuficiência cardíaca (IC) nas últimas décadas, seu prognóstico permanece desfavorável. Embora existam muitos biomarcadores que podem ajudar a prever o prognóstico de pacientes com IC, há necessidade de biomarcadores mais simples, menos dispendiosos e mais facilmente disponíveis. Objetivo Avaliar o valor preditivo do valor pan-imune-inflamatório (PIV, do inglês pan-immune-inflammation value) em pacientes com IC agudamente descompensada. Métodos Analisamos 409 pacientes com IC com fração de ejeção reduzida internados por IC aguda descompensada. Os pacientes foram divididos em 3 grupos de acordo com os tercis de PIV: tercil 1 (PIV < 357,25), tercil 2 (PIV ≥ 357,25 e < 834,55) e tercil 3 (PIV ≥ 834,55). Foram considerados estatisticamente significativos valores de p < 0,05. Curvas de Kaplan-Meier e modelos de regressão de riscos proporcionais de Cox foram utilizados para avaliar a associação entre PIV e mortalidade por todas as causas. O desfecho primário foi mortalidade por todas as causas em 5 anos, e o desfecho secundário compreendeu a mortalidade por todas as causas intra-hospitalar em 30 dias, em 180 dias e em 1 ano Resultados Mostramos que valores mais elevados de PIV estavam associados a desfechos primários e secundários. A curva de Kaplan-Meier mostrou que pacientes com valores mais elevados de PIV apresentaram risco aumentado de mortalidade por todas as causas em curto e longo prazo (log-rank p < 0,001). Na análise multivariada, o PIV foi identificado como um preditor independente de mortalidade por todas as causas em longo prazo em pacientes com IC aguda descompensada, e observamos um aumento de 1,96 vezes no risco de um evento (razão de chances: 1,96; intervalo de confiança de 95%: 1,330 a 2,908; p = 0,001). Conclusões Nosso estudo mostrou que o novo biomarcador PIV pode ser usado como preditor de prognóstico em pacientes com IC aguda descompensada.
1 March 2026 in Circulation: Cardiovascular Interventions
BACKGROUND: Isolated coronary artery ectasia (CAE) is a less common form of CAE. The clinical significance of isolated CAE has not been elucidated yet. We aimed to compare the patients with myocardial infarction (MI) due to isolated CAE with the patients without CAE. METHODS: We retrospectively included patients who underwent coronary angiography with a diagnosis of first MI caused by isolated CAE. We excluded patients with >20% stenosis in any vessel other than the lesion responsible for the MI. A second group of patients with MI without CAE was selected as the control group. The primary outcome was the composite of all-cause death and nonfatal recurrent MI occurring after index hospitalization. RESULTS: A total of 404 patients were included. Overall, 63.9% of MIs were ST-elevation MI. Almost all patients in the isolated CAE group had multivessel diffuse ectasia, with 71.3% classified as Markis I, and 26.7% as Markis II. Death or MI recurrence occurred in 54 (26.7%) patients in the isolated CAE group and 33 (16.3%) patients in the control group ( P =0.011). Death occurred in 8 (4.0%) patients in the isolated CAE group versus 6 (3.0%) patients in the control group; recurrent MI in 46 (22.8%) versus 27 (13.4%) patients, respectively. Stent thrombosis was more common in the CAE group compared with the control group (8.9% versus 1.5%; P <0.001). In multiple variable analysis, the presence of CAE was associated with death/recurrent MI (hazard ratio, 1.84 [95% CI, 1.11–3.05]; P =0.017), and recurrent MI (hazard ratio, 2.07 [95% CI, 1.08–3.96]; P =0.029). CONCLUSIONS: The patients with MI due to isolated CAE had a higher risk of recurrent MI and stent thrombosis compared with the patients without CAE. In this study, the rate of recurrent MI from the index infarct artery was also higher in the patients with CAE.
24 April 2026 in Annals of Noninvasive Electrocardiology
Objective: Serum albumin/creatinine ratio (sACR) integrates nutritional–inflammatory status and renal reserve. We evaluated its ability to predict 1-year reintervention for symptomatic graft occlusion in patients undergoing prosthetic above-knee femoropopliteal bypass for peripheral artery disease (PAD). Methods: This single-center retrospective study included 132 adults (7 women, 125 men) who underwent Dacron above-knee femoropopliteal bypass. The primary analysis evaluated preoperative sACR as a continuous variable. For descriptive comparisons and Kaplan–Meier visualization, patients were stratified according to the median preoperative sACR value (3.77), yielding two groups: <3.77 vs. ≥3.77. The primary endpoint was reintervention for symptomatic graft occlusion confirmed by imaging. Discrimination was assessed using ROC analysis, and the ROC-derived cutoff was interpreted as an exploratory threshold rather than a validated clinical decision point. Associations with 1-year reintervention were assessed using Cox proportional hazards regression analysis (age, diabetes, hypertension, smoking, coronary artery disease, hemodialysis-dependent chronic kidney disease, hemoglobin level, GFR, total protein level, antiplatelet use, and anticoagulant use). Results: Most baseline characteristics were comparable between groups; however, hemodialysis-dependent chronic kidney disease was more frequent in the low-sACR group. Reintervention occurred significantly more often in the low-sACR group from month 1 onward. sACR significantly discriminated 1-year events (AUC = 0.736; p < 0.001). The optimal cutoff was ≤3.7 (sensitivity 90.9%, specificity 64.6%). Higher sACR was associated with lower 1-year event risk in both univariate and multivariate models (adjusted HR 0.61, 95% CI 0.43–0.87; p = 0.007). Conclusions: Preoperative sACR is a practical biomarker associated with early and 1-year reintervention risk after prosthetic above-knee femoropopliteal bypass and may aid perioperative risk stratification.
Introduction: Graves’ disease is associated with cardiovascular alterations. Data on the left ventricular (LV) function and left atrial (LA) mechanics in Graves’ disease remain limited. This study investigated the relationship between disease duration and myocardial deformation parameters, including LA strain and LV global longitudinal strain (LV-GLS). Methods: In this cross-sectional study, 90 patients with Graves’ disease underwent comprehensive echocardiographic assessment. Disease duration was classified as short (≤2 years) or long (>2 years) based on receiver operating characteristic analysis. LA reservoir strain (LASr), conduit strain (LAScd), contractile strain (LASct), and LV-GLS were measured. In addition, strain parameters were compared between patients according to thyroid status (euthyroid vs. hyperthyroid). Results: Patients with longer disease duration showed significantly reduced LASr (36.9 ± 12.0% vs. 46.3 ± 11.0%, p = 0.001), LAScd (−20.2 ± 9.3% vs. −26.3 ± 9.4%, p = 0.007), LASct (−17.0 ± 6.4% vs. −19.9 ± 5.9%, p = 0.045), and absolute LV-GLS (20.8% [18.4%–24.9%] vs. 24.3% [21.7%–27.4%], p = 0.007). Disease duration correlated negatively with LASr (r = −0.340, p < 0.001) and absolute LV-GLS (r = −0.311, p = 0.003). Multivariate analysis identified LASr (OR = 0.947, p = 0.017) and LV-GLS (OR = 0.838, p = 0.020) as independent predictors of prolonged disease duration. In euthyroid patients with longer disease duration, strain parameters were significantly lower than in hyperthyroid patients with shorter duration. Conclusion: Longer Graves’ disease duration is associated with progressive subclinical impairment of atrial and ventricular mechanics, with strain abnormalities evident even in euthyroid patients. These findings highlight the cumulative impact of disease chronicity and support the use of speckle-tracking echocardiography for early detection of myocardial dysfunction and closer cardiovascular monitoring in this population.
Heart failure with preserved ejection fraction (HFpEF) constitutes nearly half of all heart failure cases and represents a complex clinical syndrome characterised by impaired ventricular relaxation...